STRIDE™
DNA Damage
Detection Assays
STRIDE™
DNA Damage
Detection Assays
Advantages
Biologically proximal
STRIDE™ is designed to detect DNA ends directly at the site of DNA damage, providing a measurement that is independent of the DNA Damage Response, in contrast to classic surrogate protein markers.
Individual DNA break levels
STRIDE™ allows to quantify even a single DNA lesion, which translates into unprecedented sensitivity in measurements of the pharmacodynamic effects of drug candidates.
Selectivity you need
With STRIDE™ both single- or double-strand DNA breaks can be quantified, which contributes to better understanding of the mode of action of therapeutics impacting DNA integrity.
Spatially resolved DNA damage
STRIDE™ assays allow you to detect and quantify DNA ends at the sites of DNA breaks or cytosolic DNA fragments in selected subcellular compartments.
DNA Damage
Detection Assays
SSBs
Detection of single-strand DNA breaks
sSTRIDE™
DSBs
Detection of double-strand DNA breaks
dSTRIDE™
How STRIDE™ works
Proprietary STRIDE™ technology is a fluorescence-based method, which directly labels DNA damage sites and detects individual DNA lesions. Strong signal amplification allows for robust and reliable quantification of DNA damage, which translates into impactful values for your research and business.
Sensitive detection of single-strand DNA breaks by sSTRIDE™
Sensitive detection of double-strand DNA breaks by dSTRIDE™
LABELING. Enzymatic modification of a single-strand break with modified nucleotides .
RECOGNITION. Attachment of a pair of primary
antibodies to the incorporated nucleotides.
DETECTION. Secondary antibodies binding and strong STRIDE™ signal enhancement on closely localized antibody complexes.
Sensitive detection of double-strand DNA breaks by dSTRIDE™
LABELING. Direct enzymatic incorporation of nucleotide analogues to DNA ends within double-strand breaks.
RECOGNITION. Attachment of a pair of primary antibodies to the labelled DNA ends.
DETECTION. Secondary antibodies binding and strong STRIDE™ signal enhancement on closely localized antibody complexes.